VINC was a penny stock and is now in the near penny category as this biotech stock has had
a great run in the past 10 days. On the 30 minute chart, 225 shares are bought at low prices
and 125 shares are sold for profit with 100 shares still running as the momentum slows.
Overall, the trades where profitable averaging 12% daily in an average trade of 4.5...